New treatment option for Hereditary Cancer Syndromes
Official title Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening
ClinicalTrials.gov ID: NCT07052266
What this study is testing
What is MyRisk Hereditary Cancer Test?
MyRisk Hereditary Cancer Test is an investigational medicine, being studied as a potential treatment for hereditary cancer syndromes.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The investigators hypothesize that pregnancy and preconception care may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal or preconception/fertility care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55, women only
You may be able to join if
- Age 18 years - 55 years
- Pregnant patients receiving obstetrical-related care or receiving preconception/fertility care at a WCM-affiliated enrollment site.
- Patients who have elected to undergo OCS with the WCM-affiliated obstetrics provider
- Patients with prior OCS but planned to repeat OCS are eligible
- Patients can speak and read in English or Spanish
You likely can't join if
- Patients who have previously completed a multigene hereditary cancer syndrome panel
- Patients who have a hematologic cancer or hematologic pre-cancer
- Patients who have a history of an autologous bone marrow transplant
The study team makes the final eligibility decision.
Where it's taking place
- Brooklyn, New York, United States
- New York, New York, United States
- Queens, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brooklyn, New York, United States; New York, New York, United States; Queens, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.